The Role of Genomic Scores in the Management of Prostate Cancer Patients: A Comprehensive Narrative Review
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Genomic score testing, including polygenic risk scores (PRSs) and genomic classifiers (GCs), aids prostate cancer (PCa) management. These tools enhance risk stratification and personalized treatment decisions for better patient outcomes.
Area Of Science
- Oncology
- Genetics
- Precision Medicine
Background
- Traditional clinical and pathological parameters have limitations in prostate cancer (PCa) management.
- Genomic score testing offers advanced tools for precision medicine in PCa.
- Polygenic risk scores (PRSs) and tumor-derived genomic classifiers (GCs) are key genomic tools.
Purpose Of The Study
- To review and analyze current evidence on genomic testing in prostate cancer.
- To focus on available assays, clinical applications, and predictive/prognostic value.
- To highlight the potential of genomic tools in enhancing personalized PCa care.
Main Methods
- Review of current literature on genomic score testing in prostate cancer.
- Analysis of polygenic risk scores (PRSs) and tumor-derived genomic classifiers (GCs).
- Evaluation of clinical applications and prognostic value of genomic assays.
Main Results
- Genomic score tests are categorized into PRSs and GCs.
- PRSs identify individuals with higher genetic susceptibility for tailored screening.
- GCs provide prognostic information to guide treatment decisions, including active surveillance.
Conclusions
- Genomic testing, when integrated with clinical data, significantly enhances personalized PCa care.
- International guidelines recommend selective use of genomic tests when they impact clinical management.
- Genomic tools should be increasingly considered in routine prostate cancer clinical practice.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
Genomics is the science of genomes: it is the study of all the genetic material of an organism. In humans, the genome consists of information carried in 23 pairs of chromosomes in the nucleus, as well as mitochondrial DNA. In genomics, both coding and non-coding DNA is sequenced and analyzed. Genomics allows a better understanding of all living things, their evolution, and their diversity. It has a myriad of uses: for example, to build phylogenetic trees, to improve productivity and...